Experimental Factor Ontology (EFO) Information | |
Identifier | EFO_1001516 |
Description | serous carcinoma located in the ovary | Trait category |
Cancer
|
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS000069 (PRS_sEOC) |
PGP000048 | Yang X et al. J Med Genet (2018) |
Serous epithelial ovarian cancer | ovarian serous carcinoma | 15 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000069/ScoringFiles/PGS000069.txt.gz |
PGS003385 (best_OV) |
PGP000413 | Namba S et al. Cancer Res (2022) |
Ovarian serous carcinoma | ovarian serous carcinoma | 144,810 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003385/ScoringFiles/PGS003385.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM000189 | PGS000069 (PRS_sEOC) |
PSS000108| European Ancestry| 4,095 individuals |
PGP000048 | Yang X et al. J Med Genet (2018) |
Reported Trait: serous epithelial ovarian cancer | OR: 1.43 [1.29, 1.58] | C-index: 0.6 [0.57, 0.63] | — | — | — |
PPM016260 | PGS003385 (best_OV) |
PSS010083| European Ancestry| 143,259 individuals |
PGP000413 | Namba S et al. Cancer Res (2022) |
Reported Trait: ovarian serous carcinoma | — | AUROC: 0.717 | R²: 0.0142 | age, top 20 genetic principal components | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000108 | Adjudicated endpoint determined from medical notes by an outcome review committee | Mean = 11.1 years IQR = [10.0, 12.0] years |
[ ,
0.0 % Male samples |
Mean = 63.0 years Range = [50.0, 74.0] years |
European | — | UKCTOCS | — |
PSS000108 | Adjudicated endpoint determined from medical notes by an outcome review committee | Mean = 11.1 years IQR = [10.0, 12.0] years |
[ ,
0.0 % Male samples |
Mean = 63.0 years Range = [50.0, 74.0] years |
European | — | UKCTOCS | — |
PSS010083 | C56, histology was one of the followings: Papillary serous cystadenocarcinoma; Serous cystadenocarcinoma; Serous cystadenoma, borderline malignancy; Serous papillary cystic tumor of borderline malignancy; Serous surface papillary carcinoma | — | [
|
— | European (British) |
— | UKB | Controls were samples without any cancer diagnosis or self-reported cancer |